Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Allergy Clin Immunol. 2015 Oct 30;137(3):767–73.e6. doi: 10.1016/j.jaci.2015.05.053

Figure 2. FXIII mRNA expression correlates with % reversibility of FEV1 % predicted to β-agonist, and with FEV1/FVC % predicted.

Figure 2

Some of the correlations described in Table 3 were graphed with non-severe (n=34) shown in blue circles and severe subjects (n=22) shown in red triangles.